Validation is not enough: Longitudinal evidence of post-deployment fragility in clinical AI systems
Open accessAbstract
Pre-deployment validation is commonly used to establish the safety and effectiveness of clinical artificial intelligence systems, but acceptable validation performance does not guarantee stable behavior after deployment into routine clinical workflows. We conducted a longitudinal retrospective observational study of four clinically deployed AI systems operating across distinct clinical domains and workflows within a large healthcare organization. Using routinely collected clinical data, outcome labels, and operational telemetry, we compared validation-era performance with post-deployment behavior over extended observation periods. Analyses focused on temporal patterns of discrimination, calibration, data availability, latency, and workflow-related signals, with particular attention to label-dependent and label-independent monitoring. Across all systems, validation-era performance did not persist as a stable operational property after deployment. Calibration drift emerged consistently and often preceded detectable changes in discrimination. Workflow-associated changes in data availability and timing were more strongly and consistently associated with degradation than population-level indicators. Label-independent operational signals, including input missingness and data latency, provided early indication of emerging fragility, whereas outcome-based monitoring was delayed by label latency and documentation processes. These findings suggest that post-deployment fragility can be a structural property of clinical AI systems embedded in evolving workflows. Effective governance therefore requires lifecycle-oriented monitoring strategies that combine calibration reassessment with operational telemetry throughout deployment.
AI snapshot
Written from the paper’s full text.
TL;DR
In a longitudinal retrospective study of four clinically deployed AI systems, validation-era performance did not persist after deployment; calibration drift emerged earlier and more consistently than discrimination decline. Workflow-associated telemetry such as input missingness, data latency, and feature availability was more strongly associated with degradation than population-level indicators, supporting calibration-aware, telemetry-first post-deployment monitoring.
Key findings
- Across Systems A–D, validation AUROC ranged from 0.80 to 0.86 and calibration slopes from 0.99 to 1.03; by mature deployment, AUROC fell to 0.75–0.82 and calibration slopes to 0.69–0.89, with calibration intercepts shifting negative (e.g., System A slope 1.01→0.71, intercept 0.02→−0.36; System B slope 0.99→0.69, intercept 0.01→−0.41).
- Calibration changed earlier than discrimination: mean validation-to-early-deployment Δ calibration slope was −0.08, −0.11, and −0.14 for 3-, 6-, and 9-month early-deployment definitions, versus mean Δ AUROC of −0.01, −0.02, and −0.03.
- Workflow-associated indicators showed stronger associations with calibration degradation than population indicators: input missingness βstd ranged from −0.42 to −0.21, data latency from −0.35 to −0.08, and feature availability change from −0.37 to −0.19, while population demographics ranged from −0.06 to −0.03. In leave-one-system-out analyses, telemetry blocks explained ΔR² 0.21–0.28 versus 0.05–0.07 for population blocks.
- Three recurrent failure modes were identified: silent calibration failure under preserved discrimination, workflow-associated degradation without large population shift, and governance failure due to outcome-label latency.
Methods
- Retrospective, longitudinal observational study of four clinically deployed AI systems (A–D) spanning acute-care EHR prediction, sepsis risk stratification, specialty outpatient diagnostic support, and radiology imaging-derived outcome risk; observation periods were 18–24 months and inference volumes ranged from 68,000 to 1,240,000 events. No model parameters, feature definitions, decision thresholds, or intended use changed during observation.
- Performance was compared across validation, early deployment (first 6 months primary; sensitivity 3 and 9 months), and mature deployment (>6 months), using AUROC, AUPRC, calibration slope/intercept, and operational telemetry including input missingness, data latency, feature availability, inference volume, and interaction logs.
- Analyses used monthly aggregation, bootstrap confidence intervals, mixed-effects linear regression with a system-level random intercept, lagged telemetry analyses, leave-one-system-out robustness, and alternative regression specifications; data came from EHR, laboratory, and imaging systems, with outcome labels from routine documentation and task-dependent delays.
Limitations
- The paper states that empirical scope is limited to a finite set of systems within specific institutional contexts, so quantitative effect sizes and degradation rates should not be interpreted as universal; it also states that abstraction across heterogeneous tasks and modalities simplifies task-specific nuances.
- The paper states that it did not prospectively elicit clinician tolerance thresholds or measure trust/reliance/abandonment, did not model organizational responses or label feedback, and does not evaluate compliance with specific regulatory frameworks or prescribe regulatory thresholds.
- Evident from the text: only four anonymized systems were studied, vendor/model details are withheld, telemetry availability varied by system (e.g., alert acknowledgement/override was NA for Systems C and D), and the authors explicitly interpret drift associations as non-causal.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
26 of 31 cited sources checked · 10 supported · 1 flagged · accuracy not yet measured
- Premisecitation
These frameworks primarily focus on evidence generation at the point of evaluation and provide limited guidance on how performance degradation should be detected and managed during routine clinical operation, particularly when outcome labels are delayed, incomplete, or influenced by the model's own use.
“However, these frameworks primarily focus on evidence generation at the point of evaluation and provide limited guidance on how performance degradation should be detected and managed during routine clinical operation, particularly when outcome labels are delayed, incomplete, or influenced by the model’s own use [25–27].”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [25] SPIRIT-AI and CONSORT-AI Working Group, 2020, Guidelines for clinical trial protocols for interventions involving artificial intelligence: The SPIRIT-AI Extension, BMJ source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [26] SE Davis, 2024, Sustainable deployment of clinical prediction tools-a 360° approach to model maintenance, J Am Med Inform Assoc source
Split into 2 atoms — 0 confirmed, 0 partially supported, 2 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured - cites [27] V Subasri, 2025, Detecting and remediating harmful data shifts for the responsible deployment of clinical AI models, JAMA Netw Open source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
- Premisecitation
Care-process shifts, especially changes in test-ordering and documentation practices, can alter both feature availability and the meaning of missingness (informative missingness), which can affect deterioration-prediction performance even when underlying patient mix is relatively stable.
“Care-process shifts – especially changes in test-ordering and documentation practices – can alter both feature availability and the meaning of missingness (“informative missingness”), which can affect deterioration-prediction performance even when underlying patient mix is relatively stable [11,12].”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [11] T Sim, 2025, Preserving informative presence: How missing data and imputation strategies affect the performance of an ai-based early warning score, J Clin Med source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [12] J Singh, 2021, On missingness features in machine learning models for critical care: Observational study, JMIR Med Inform source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
- Premisecitation
Clinical practice patterns learned from EHR data can vary substantially across years.
“Clinical practice patterns learned from EHR data can vary substantially across years [6].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [6] JH Chen, 2017, Decaying relevance of clinical data towards future decisions in data-driven inpatient clinical order sets, Int J Med Inform source
- Premisecitation
Clinician interaction with decision support systems can recursively influence both inputs and outcomes, creating feedback loops that invalidate original performance assumptions.
“Complementary work on alert fatigue and automation bias shows that clinician interaction with decision support systems can recursively influence both inputs and outcomes, creating feedback loops that invalidate original performance assumptions [19,20].”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [19] F Kücking, 2024, Automation bias in AI-decision support: Results from an empirical study, Stud Health Technol Inform source
- cites [20] JS Ancker, 2017, Effects of workload, work complexity, and repeated alerts on alert fatigue in a clinical decision support system, BMC Med Inform Decis Mak source
The Discussion reports that alert acceptance fell as the number of reminders and repeated reminders increased, supporting the narrower point that interaction with decision support is associated with clinician responses. It does not show that those responses recursively change system inputs or create feedback loops that invalidate performance assumptions. The Discussion also says the study did not support desensitization from repeated exposure over time. (LLM, conf=0.85)
Experimental — accuracy not yet measured
- Premisecitation
External evaluations of widely deployed proprietary systems, such as the Epic Sepsis Model, have reported poor discrimination and calibration in routine clinical use despite broad adoption.
“external evaluations of widely deployed proprietary systems, such as the Epic Sepsis Model, have reported poor discrimination and calibration in routine clinical use despite broad adoption [15,16].”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [15] A Wong, 2021, External validation of a widely implemented proprietary sepsis prediction model in hospitalized patients, JAMA Intern Med source
- cites [16] P Papareddy, 2025, Transforming sepsis management: AI-driven innovations in early detection and tailored therapies, Crit Care source
The Early Detection and Early Warning Systems section reports that the widely adopted Epic Sepsis Model had poor discrimination in independent validation (AUC about 0.63). The Foundational Issues section also reports that an external evaluation found it missed 67% of sepsis cases. The paper discusses poor calibration as a possible limitation of models generally, but does not report a finding of poor calibration for the Epic Sepsis Model specifically; page numbers are unavailable in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
The performance of a customized SAPS-II ICU mortality model changed over time, illustrating how temporal changes in clinical case mix and care processes can affect the reliability of severity-adjustment models.
“Minne et al. showed that the performance of a customized SAPS-II ICU mortality model changed over time, illustrating how temporal changes in clinical case mix and care processes can affect the reliability of severity-adjustment models [10].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [10] L Minne, 2012, Effect of changes over time in the performance of a customized SAPS-II model on the quality of care assessment, Intensive Care Med source
- Premisecitation
A pneumonia detection model learned site-specific and non-clinical confounders, resulting in large performance differences across hospitals despite strong internal validation.
“Zech et al. showed that a pneumonia detection model learned site-specific and non-clinical confounders, resulting in large performance differences across hospitals despite strong internal validation [14].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [14] JR Zech, 2018, Variable generalization performance of a deep learning model to detect pneumonia in chest radiographs: A cross-sectional study, PLoS Med source
- Premisecitation
Predictive models may lose calibration and discrimination over time within the same institution, even when patient demographics and nominal case severity remain relatively stable.
“Longitudinal analyses have shown that predictive models may lose calibration and discrimination over time within the same institution, even when patient demographics and nominal case severity remain relatively stable [9].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [9] P Cabanillas Silva, 2024, Longitudinal model shifts of machine learning-based clinical risk prediction models: Evaluation study of multiple use cases across different hospitals, J Med Internet Res source
The Discussion (Principal Findings; page unavailable) reports calibration shifts for the delirium and sepsis models at the hospitals, and the Results (Data Source Analysis; page unavailable) reports a consistent proportion of women and men over time. But discrimination did not significantly decline: AUROCs remained stable across years at both hospitals. The copy also does not establish that case severity remained stable. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
Dataset shift in medicine is the rule rather than the exception, driven by changes in care delivery, clinical incentives, and documentation rather than by random variation alone.
“Finlayson et al. argue that dataset shift in medicine is “the rule rather than the exception,” driven by changes in care delivery, clinical incentives, and documentation rather than by random variation alone [8].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [8] SG Finlayson, 2021, The clinician and dataset shift in artificial intelligence, New England Journal of Medicine source
In the 'TO THE EDITOR' section (page not available), the paper describes dataset shift as a major driver of clinical AI malfunction and lists common causes, including changes in behavior such as reimbursement incentives. It does not say that dataset shift is 'the rule rather than the exception' or specifically identify documentation changes as a cause. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Interpretationown data
Degradation may be linked to how data are produced within evolving workflows and information systems, not only to who the patients are.
“This supports a workflow-aware interpretation of post-deployment fragility: degradation may be linked to how data are produced within evolving workflows and information systems, not only to who the patients are [8,18,33,35].”
Quote in the paperSubstantial claim3 of 4 sources checked- cites [8] SG Finlayson, 2021, The clinician and dataset shift in artificial intelligence, New England Journal of Medicine source
- cites [18] A Subbaswamy, 2020, From development to deployment: dataset shift, causality, and shift-stable models in health AI, Biostatistics source
- cites [33] ES Andersen, 2024, Monitoring performance of clinical artificial intelligence in health care: A scoping review, JBI Evid Synth source
The Introduction says clinical AI performance may change during deployment when its operating environment changes. The Results’ input-monitoring section also discusses detecting shifts in model inputs. Neither passage specifically links degradation to evolving clinical workflows or information systems, so the source supports the broader point but not that proposed mechanism. (LLM, conf=0.79)
Experimental — accuracy not yet measured - cites [35] PL Day, 2026, Discovery of an artificial intelligence label feedback loop: How the success of a clinically implemented artificial intelligence algorithm has created an unforeseen challenge to algorithm retraining, Clin Chem source
- Interpretationown data
The validation-deployment gap arises within a single institution over time, not only through cross-site transportability failures.
“This extends critiques of retrospective validation by showing the validation–deployment gap arises within a single institution over time, not only through cross-site transportability failures [15,33].”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [15] A Wong, 2021, External validation of a widely implemented proprietary sepsis prediction model in hospitalized patients, JAMA Intern Med source
The Introduction says Epic developed and validated the model using data from three health systems in 2013–2015; the Methods describe this study’s later evaluation at Michigan Medicine. The Discussion reports substantially worse performance than Epic’s earlier figures, supporting a validation–deployment gap, but the paper does not establish that the gap arose within one institution over time rather than across sites. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [33] ES Andersen, 2024, Monitoring performance of clinical artificial intelligence in health care: A scoping review, JBI Evid Synth source
The Introduction (page unavailable) says clinical AI performance may change during deployment and that acceptable performance at validation does not guarantee sustained adequacy. This supports a gap developing over time, but our copy does not establish the more specific claim that it arises within a single institution rather than through cross-site differences. (LLM, conf=0.82)
Experimental — accuracy not yet measured
- Findingown data
Workflow-associated changes in data availability and timing were more strongly and consistently associated with post-deployment degradation than population-level indicators.
“Workflow-associated changes in data availability and timing were more strongly and consistently associated with degradation than population-level indicators.”
Quote in the paperSubstantial claim- Rests on an assumption: Operational telemetry indicators (input missingness, data latency, feature availability) validly capture workflow-induced drift and are not merely proxies for other unmeasured factors.
- Findingown data
Outcome-based monitoring was delayed by label latency and documentation processes.
“whereas outcome-based monitoring was delayed by label latency and documentation processes.”
Quote in the paperSubstantial claim- Rests on an assumption: Outcome labels derived from routine clinical documentation are accurate and consistent enough to serve as ground truth for performance evaluation.
- Findingown data
Label-independent operational signals, including input missingness and data latency, provided early indication of emerging fragility.
“Label-independent operational signals, including input missingness and data latency, provided early indication of emerging fragility”
Quote in the paperSubstantial claim- Rests on an assumption: Operational telemetry indicators (input missingness, data latency, feature availability) validly capture workflow-induced drift and are not merely proxies for other unmeasured factors.
- Findingown data
Across all four clinically deployed AI systems, validation-era performance did not persist as a stable operational property after deployment.
“Across all systems, validation-era performance did not persist as a stable operational property after deployment.”
Quote in the paperSubstantial claim- Rests on an assumption: The validation-era performance metrics are a valid baseline for comparison, and the validation data are comparable to deployment data except for the factors studied.
- Findingown data
AUROC changes during early deployment remained smaller in magnitude than calibration changes.
“In contrast, AUROC changes during early deployment remained smaller in magnitude, supporting the interpretation that calibration degradation emerged earlier than discrimination decline (Table 6).”
Quote in the paperSubstantial claim - Findingown data
In Systems A and B, calibration slope attenuation and intercept drift emerged within months, preceding AUROC decline.
“In Systems A and B, calibration slope attenuation and intercept drift emerged within months, preceding AUROC decline.”
Quote in the paperSubstantial claim - Findingown data
Workflow-associated telemetry signals, particularly missingness and latency, continued to precede or co-evolve with calibration degradation.
“Workflow-associated telemetry signals, particularly missingness and latency, continued to precede or co-evolve with calibration degradation.”
Quote in the paperSubstantial claim - Findingown data
Input missingness and data latency preserved negative associations with calibration slope in all tested regression specifications.
“Input missingness and data latency preserved negative associations with calibration slope in all tested specifications.”
Quote in the paperSubstantial claim - Findingown data
Leave-one-system-out analyses preserved the direction and ranking of associations between workflow-associated indicators and calibration degradation.
“Leave-one-system-out analyses preserved the direction and ranking of associations between workflow-associated indicators and calibration degradation.”
Quote in the paperNot a substantial claim - Findingown data
Feature availability change was negatively associated with calibration slope across Systems A-D, with standardized coefficients ranging from -0.19 to -0.37.
“| Feature availability change | -0.22 (-0.35 to -0.09) | -0.34 (-0.48 to -0.20) | -0.19 (-0.31 to -0.07) | -0.37 (-0.51 to -0.23) |”
Quote in the paperSubstantial claim- Rests on an assumption: Operational telemetry indicators (input missingness, data latency, feature availability) validly capture workflow-induced drift and are not merely proxies for other unmeasured factors.
- Findingown data
Calibration changed earlier and more consistently than discrimination after deployment.
“Calibration changed earlier and more consistently than discrimination.”
- Also stated in: § 3.4. Longitudinal performance and telemetry trajectories · plain
“Discrimination remained relatively stable early after deployment and declined later, whereas calibration deviated earlier and more consistently from validation benchmarks.”
- Also stated in: § 4.1. Principal findings and conceptual contribution · plain
“Calibration degradation consistently preceded and exceeded discrimination loss after deployment: across multiple systems, slopes and intercepts drifted substantially while AUROC remained acceptable for extended periods.”
Quote in the paperSubstantial claim - Also stated in: § 3.4. Longitudinal performance and telemetry trajectories · plain
- Findingown data
Rolling-window analyses confirmed sustained calibration divergence rather than transient instability.
“Rolling-window analyses confirmed sustained calibration divergence rather than transient instability (Fig 2).”
Quote in the paperSubstantial claim - Findingown data
Input missingness and data latency were most strongly associated with declining calibration slope in Systems A and B.
“Input missingness and data latency were most strongly associated with declining calibration slope in Systems A and B.”
Quote in the paperSubstantial claim - Findingown data
Across systems, post-deployment performance diverged from validation-era estimates despite unchanged model parameters, feature definitions, decision thresholds, and intended use.
“Across systems, post-deployment performance diverged from validation-era estimates despite unchanged model parameters, feature definitions, decision thresholds, and intended use.”
Quote in the paperSubstantial claim - Findingown data
Calibration degradation was the earliest and most consistent post-deployment failure pattern.
“calibration degradation was the earliest and most consistent post-deployment failure pattern.”
Quote in the paperSubstantial claim - Findingown data
Performance degradation unfolded gradually rather than as abrupt shifts.
“Performance degradation unfolded gradually rather than as abrupt shifts (Fig 1).”
Quote in the paperSubstantial claim - Findingown data
Population demographics shift was not consistently associated with calibration slope across Systems A-D.
“| Population demographics shift | -0.05 (-0.12 to 0.03) | -0.04 (-0.11 to 0.04) | -0.03 (-0.10 to 0.05) | -0.06 (-0.14 to 0.02) |”
Quote in the paperNot a substantial claim - Findingown data
Across phase definitions, calibration changed more consistently than discrimination.
“Across phase definitions, calibration changed more consistently than discrimination.”
Quote in the paperNot a substantial claim - Findingown data
Calibration degradation remained detectable earlier than discrimination decline across alternative aggregation windows.
“Calibration degradation remained detectable earlier than discrimination decline across alternative aggregation windows.”
Quote in the paperNot a substantial claim - Findingown data
Across systems, degradation often appeared first as calibration failure without comparable loss of discrimination.
“Across systems, degradation often appeared first as calibration failure without comparable loss of discrimination.”
Quote in the paperSubstantial claim - Findingown data
The direction and timing of the main findings were preserved across windowing specifications.
“The direction and timing of the main findings were preserved across windowing specifications.”
Quote in the paperSubstantial claim - Findingown data
Feature availability change showed the strongest association in Systems B and D.
“Feature availability change showed the strongest association in Systems B and D.”
Quote in the paperNot a substantial claim - Findingown data
Confidence intervals widened during deployment, indicating increased performance heterogeneity under routine conditions.
“Confidence intervals widened during deployment, indicating increased performance heterogeneity under routine conditions.”
Quote in the paperSubstantial claim - Findingown data
Input missingness was negatively associated with calibration slope across Systems A-D, with standardized coefficients ranging from -0.21 to -0.42.
“| Input missingness | -0.42 (-0.56 to -0.29) | -0.38 (-0.52 to -0.25) | -0.24 (-0.37 to -0.11) | -0.21 (-0.34 to -0.08) |”
Quote in the paperSubstantial claim- Rests on an assumption: Operational telemetry indicators (input missingness, data latency, feature availability) validly capture workflow-induced drift and are not merely proxies for other unmeasured factors.
- Findingown data
Workflow-associated indicators showed larger and more consistent negative associations with calibration slope than population-related indicators.
“Workflow-associated indicators showed larger and more consistent negative associations with calibration slope than population-related indicators.”
- Also stated in: § 3.3. Quantitative associations between drift indicators and calibration degradation · boosted
“Overall, workflow-associated indicators showed stronger and more consistent associations with post-deployment calibration degradation than population-related indicators.”
Quote in the paperSubstantial claim - Also stated in: § 3.3. Quantitative associations between drift indicators and calibration degradation · boosted
- Findingown data
The temporal ordering between telemetry change and subsequent performance degradation was preserved in leave-one-system-out analyses.
“The temporal ordering between telemetry change and subsequent performance degradation was also preserved.”
Quote in the paperSubstantial claim - Findingown data
Calibration drift consistently emerged as an early failure mode across the deployed systems.
“The consistent emergence of calibration drift as an early failure mode suggests that calibration stability should be treated as a primary safety objective”
- Also stated in: § 5. Conclusions · hedged
“Across systems, degradation was progressive, often appeared first as calibration drift, and was more consistently associated with workflow-related telemetry signals such as missingness, latency, and feature availability than with broad population-level indicators.”
Quote in the paperSubstantial claim - Also stated in: § 5. Conclusions · hedged
- Findingown data
Workflow-aware signals were more consistently associated with degradation than broad population-level indicators.
“the results of this study indicate that workflow-aware signals were more consistently associated with degradation and may be more actionable for monitoring.”
- Also stated in: § 5. Conclusions · plain
“Across systems, degradation was progressive, often appeared first as calibration drift, and was more consistently associated with workflow-related telemetry signals such as missingness, latency, and feature availability than with broad population-level indicators.”
Quote in the paperSubstantial claim - Also stated in: § 5. Conclusions · plain
- Findingown data
Across systems, degradation was progressive.
“Across systems, degradation was progressive”
Quote in the paperSubstantial claim - Findingown data
This longitudinal analysis of four deployed clinical AI systems shows that acceptable validation performance did not persist as a stable operational property after deployment.
“This longitudinal analysis of four deployed clinical AI systems shows that acceptable validation performance did not persist as a stable operational property after deployment.”
Quote in the paperSubstantial claim - Interpretationreasoning
Post-deployment fragility can be a structural property of clinical AI systems embedded in evolving workflows.
“These findings suggest that post-deployment fragility can be a structural property of clinical AI systems embedded in evolving workflows.”
Quote in the paperSubstantial claim- Rests on an assumption: The four included AI systems are representative of clinically deployed AI systems in general, such that findings about post-deployment fragility generalize to other systems and settings.
- Interpretationreasoning
Telemetry can serve as an early monitoring signal under conditions where complete outcome labels are delayed.
“These findings support the use of telemetry as an early monitoring signal under conditions where complete outcome labels are delayed.”
Quote in the paperSubstantial claim- The authors state this as an assumption: Outcome labels are assumed unavailable for real-time safety monitoring.
- Interpretationown data
This study provides empirical, longitudinal evidence that post-deployment fragility can arise systematically across clinical AI systems operating under routine conditions.
“This study provides empirical, longitudinal evidence that post-deployment fragility can arise systematically across clinical AI systems operating under routine conditions.”
Quote in the paperSubstantial claim - Interpretationreasoning
Preserved ranking does not ensure correct absolute risk estimation.
“Clinically, this failure mode is important because preserved ranking does not ensure correct absolute risk estimation.”
Quote in the paperSubstantial claim - Interpretationreasoning
This creates a governance gap in which systems may continue operating despite telemetry evidence of emerging performance degradation.
“This creates a governance gap in which systems may continue operating despite telemetry evidence of emerging performance degradation.”
Quote in the paperSubstantial claim - Interpretationreasoning
Acceptable validation performance may not provide durable assurance after deployment.
“This structure explains why acceptable validation performance may not provide durable assurance after deployment.”
Quote in the paperSubstantial claim - Interpretationown data
Operational changes in how data were generated, documented, or made available may destabilize deployed models even when broad population characteristics do not change to a comparable extent.
“This pattern indicates that operational changes in how data were generated, documented, or made available may destabilize deployed models even when broad population characteristics do not change to a comparable extent.”
Quote in the paperSubstantial claim - Interpretationown data
The observed longitudinal patterns were not artifacts of the selected temporal window.
“These analyses indicate that the observed longitudinal patterns were not artifacts of the selected temporal window.”
Quote in the paperSubstantial claim - Interpretationreasoning
Silent miscalibration is a first-order safety risk, as it distorts absolute risk estimates and threshold-based actions without triggering discrimination-focused alarms.
“Silent miscalibration is therefore a first-order safety risk, as it distorts absolute risk estimates and threshold-based actions without triggering discrimination-focused alarms, highlighting a gap between commonly reported metrics and clinically meaningful safety properties.”
Quote in the paperSubstantial claim - Interpretationown data
Increasing missingness reflected operational data availability and documentation timing rather than random feature loss.
“These patterns indicate that increasing missingness reflected operational data availability and documentation timing rather than random feature loss.”
Quote in the paperSubstantial claim - Interpretationreasoning
Under outcome-based monitoring alone, degradation would be detected only after a delay.
“Under outcome-based monitoring alone, degradation would therefore be detected only after a delay.”
Quote in the paperSubstantial claim - Interpretationown data
A second failure mode is workflow-associated degradation without comparable population-level change.
“A second failure mode was workflow-associated degradation without comparable population-level change.”
Quote in the paperSubstantial claim - Interpretationown data
Discrimination metrics alone would have delayed detection of post-deployment degradation, particularly in Systems A and B, where calibration drift emerged before substantial AUROC decline.
“These findings indicate that discrimination metrics alone would have delayed detection of post-deployment degradation, particularly in Systems A and B, where calibration drift emerged before substantial AUROC decline.”
Quote in the paperSubstantial claim - Interpretationown data
The telemetry-performance relationship was not driven by a single regression specification.
“These findings indicate that the telemetry–performance relationship was not driven by a single regression specification.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Monitoring focused primarily on AUROC would delay detection of silent calibration failure.
“Because absolute risk estimates inform thresholds and escalation decisions, monitoring focused primarily on AUROC would delay detection of this failure mode.”
Quote in the paperSubstantial claim - Interpretationown data
Operational signals were observable before or alongside performance degradation.
“Together, the telemetry and calibration trajectories indicate that operational signals were observable before or alongside performance degradation.”
Quote in the paperSubstantial claim - Interpretationreasoning
Observed changes in model behavior reflected post-deployment operating conditions rather than intentional model modification.
“Therefore, observed changes in model behavior reflected post-deployment operating conditions rather than intentional model modification.”
Quote in the paperSubstantial claim - Interpretationown data
The main finding - earlier and more consistent calibration degradation relative to discrimination decline - was not an artifact of the selected 6-month primary phase definition.
“These results indicate that the main finding – earlier and more consistent calibration degradation relative to discrimination decline – was not an artifact of the selected 6-month primary phase definition.”
Quote in the paperSubstantial claim - Interpretationown data
A third failure mode is governance failure due to outcome-label latency.
“A third failure mode was governance failure due to outcome-label latency.”
Quote in the paperSubstantial claim- The authors state this as an assumption: Outcome labels are assumed unavailable for real-time safety monitoring.
- Interpretationown data
Silent calibration failure occurs when models preserve ranking ability but systematically misestimate absolute risk.
“This represents silent calibration failure: the models preserved ranking ability but systematically misestimated absolute risk.”
Quote in the paperSubstantial claim - Study design and conductnone given
Across all systems, model architecture, feature definitions, decision thresholds, and intended use remained unchanged during the observation period.
“Across all systems, model architecture, feature definitions, decision thresholds, and intended use remained unchanged during the observation period.”
Quote in the paperSubstantial claim - Interpretationreasoning
Missingness contributed to calibration degradation by altering the information available to the model at inference time.
“This supports the interpretation that missingness contributed to calibration degradation by altering the information available to the model at inference time.”
Quote in the paperSubstantial claim - Premisereasoning
Signals such as input missingness, data latency, feature availability, score-distribution change, and interaction logs are observable at or near inference time, before downstream clinical response is fully expressed.
“Signals such as input missingness, data latency, feature availability, score-distribution change, and interaction logs are observable at or near inference time, before downstream clinical response is fully expressed.”
Quote in the paperSubstantial claim - Interpretationreasoning
The central challenge is not lack of data, but lack of conceptual and operational alignment between validation, monitoring, and governance.
“By positioning the present study alongside real deployed systems in Table 7, the analysis clarifies that the central challenge is not lack of data, but lack of conceptual and operational alignment between validation, monitoring, and governance.”
Quote in the paperNot a substantial claim - Study design and conductreasoning
The study did not estimate system-specific time-to-loss-of-trust thresholds.
“Therefore, we did not estimate system-specific time-to-loss-of-trust thresholds.”
Quote in the paperNot a substantial claim - Premiseown data
Real-world deployed clinical AI systems commonly rely on outcome labels that become available only after task-dependent delays ranging from hours or days to weeks or months.
“As summarized in Table 7, real-world deployed clinical AI systems commonly rely on outcome labels that become available only after task-dependent delays ranging from hours or days to weeks or months.”
Quote in the paperSubstantial claim - Interpretationown data
The longitudinal degradation observed in this study, and mirrored by failures in real deployments, shows that the assumption that model performance remains stable unless explicitly updated does not hold.
“The longitudinal degradation observed in this study – and mirrored by failures documented in real deployments – shows that this assumption does not hold.”
Quote in the paperSubstantial claim- The authors state this as an assumption: Current practice often treats acceptable discrimination and calibration at validation as sufficient justification for deployment, with the implicit assumption that performance will remain stable unless the model is explicitly updated.
- Interpretationreasoning
Once a deployed AI system influences clinical decisions, subsequent outcome labels may partly reflect model-guided intervention rather than the unmodified natural history of disease.
“Once a deployed AI system influences clinical decisions, subsequent outcome labels may partly reflect model-guided intervention rather than the unmodified natural history of disease.”
- Also stated in: § 4.4. Limitations and scope of interpretation · hedged
“model-generated predictions may influence clinician behavior and subsequent outcome labels, creating label feedback that complicates outcome-based reassessment.”
Quote in the paperSubstantial claim - Also stated in: § 4.4. Limitations and scope of interpretation · hedged
- Study design and conductown data
The study is grounded in real-world deployment data.
“While this study is grounded in real-world deployment data, the empirical scope is limited to a finite set of clinical AI systems operating within specific institutional contexts.”
Quote in the paperSubstantial claim - Interpretationreasoning
Many observed breakdowns can be reframed as governance failures - cases where degradation is detectable in principle but invisible under prevailing monitoring practices.
“It reframes many observed breakdowns as governance failures – cases where degradation is detectable in principle but invisible under prevailing monitoring practices.”
Quote in the paperSubstantial claim - Study design and conductnone given
The empirical scope of the study is limited to a finite set of clinical AI systems operating within specific institutional contexts.
“the empirical scope is limited to a finite set of clinical AI systems operating within specific institutional contexts.”
Quote in the paperSubstantial claim - Premisereasoning
Outcome labels rarely arrive fast enough for continuous safety assurance.
“Table 7 also underscores a common constraint: outcome labels rarely arrive fast enough for continuous safety assurance.”
Quote in the paperSubstantial claim - Interpretationreasoning
This delay makes outcome-based monitoring insufficient as the sole mechanism for timely post-deployment safety surveillance.
“This delay makes outcome-based monitoring insufficient as the sole mechanism for timely post-deployment safety surveillance.”
Quote in the paperSubstantial claim - Interpretationreasoning
Clinical AI fragility is an operational property of deployed systems under real governance constraints (e.g., delayed/biased labels).
“Together, these results frame clinical AI fragility as an operational property of deployed systems under real governance constraints (e.g., delayed/biased labels).”
Quote in the paperSubstantial claim - Premisenone given
Although telemetry such as missingness, latency, acknowledgement, and image quality is routinely available, it is rarely analyzed as a predictor of safety-relevant degradation.
“Although telemetry such as missingness, latency, acknowledgement, and image quality is routinely available, it is rarely analyzed as a predictor of safety-relevant degradation.”
Quote in the paperNot a substantial claim - Premisenone given
Most studies assess performance at isolated time points, obscuring early-stage divergence from validation behavior.
“Most studies assess performance at isolated time points, obscuring early-stage divergence from validation behavior.”
Quote in the paperNot a substantial claim - Interpretationown data
The consistency of observed failure structures across heterogeneous systems supports the broader generalizability of the qualitative findings regarding timing, observability, and governance relevance of post-deployment degradation.
“the consistency of observed failure structures across heterogeneous systems supports the broader generalizability of the qualitative findings regarding timing, observability, and governance relevance of post-deployment degradation.”
Quote in the paperSubstantial claim - Interpretationown data
Label-independent operational telemetry can provide earlier indication of degradation than outcome-based reassessment when labels are delayed.
“It demonstrates that label-independent operational telemetry can provide earlier indication of degradation than outcome-based reassessment when labels are delayed.”
Quote in the paperSubstantial claim- The authors state this as an assumption: Outcome labels are assumed unavailable for real-time safety monitoring.
- Classified as probably not a substantial claim. 30
- May combine two claims. 37
- The quote only partly states this claim. 1
Classified as probably not a substantial claim.
PremisecitationPredictive systems that do not explicitly account for causal structure are brittle to policy and workflow changes, even when statistical properties appear similar.
“Subbaswamy and Saria emphasize that predictive systems that do not explicitly account for causal structure are brittle to policy and workflow changes, even when statistical properties appear similar [18].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [18] A Subbaswamy, 2020, From development to deployment: dataset shift, causality, and shift-stable models in health AI, Biostatistics source
The opening discussion describes a pneumonia-risk model that performed well on one dataset but was vulnerable to a subtle change in ICU admission policy. Sections 1 and 2 explain how causal graphs can identify susceptibility to policy and clinical-practice shifts. The paper does not establish the added claim that this brittleness persists when statistical properties appear similar. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationFrameworks such as TRIPOD-AI and CONSORT-AI have substantially improved transparency in model development and validation, and regulatory bodies emphasize ongoing monitoring for AI/ML-enabled medical devices.
“Frameworks such as TRIPOD-AI and CONSORT-AI have substantially improved transparency in model development and validation, and regulatory bodies emphasize ongoing monitoring for AI/ML-enabled medical devices [24].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [24] GS Collins, 2024, TRIPOD+AI statement: Updated guidance for reporting clinical prediction models that use regression or machine learning methods, BMJ source
The Discussion (page unavailable) says TRIPOD+AI provides reporting recommendations that can increase transparency, and the guideline table identifies CONSORT-AI as a reporting guideline. It does not establish that these frameworks have substantially improved transparency in practice. Its discussion of regulators concerns assessing reports submitted for medical-device review, not regulatory emphasis on ongoing monitoring. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationRegulatory and reporting guidance increasingly acknowledges the need for lifecycle-based evaluation of AI systems.
“Regulatory and reporting guidance increasingly acknowledges the need for lifecycle-based evaluation of AI systems [21–23].”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [21] AA Armoundas, 2026, Total product lifecycle regulatory considerations and recommendations for generative AI-enabled medical devices, Eur Heart J Digit Health source
The Risks and risk management section describes EU AI Act requirements for living documentation, lifecycle logging, post-market monitoring, and robustness assessment throughout the lifecycle. This supports the regulatory part of the claim, but the paper does not establish that reporting guidance increasingly acknowledges lifecycle-based evaluation. (LLM, conf=0.78)
Experimental — accuracy not yet measured - cites [22] FDA. Artificial intelligence-enabled device software functions: lifecycle management and marketing submission recommendations.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [23] Final Document Good machine learning practice for medical device development: Guiding principles AUTHORING GROUP Artificial Intelligence/Machine Learning-enabled Working Group Preface 2025.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Interpretationown dataCalibration failure is structural and progressive rather than sporadic.
“This extends prior reports of temporal miscalibration [32–34] by showing calibration failure is structural and progressive rather than sporadic.”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [32] SE Davis, 2020, Detection of calibration drift in clinical prediction models to inform model updating, J Biomed Inform source
- cites [33] ES Andersen, 2024, Monitoring performance of clinical artificial intelligence in health care: A scoping review, JBI Evid Synth source
- cites [34] SE Davis, 2017, Calibration drift in regression and machine learning models for acute kidney injury, J Am Med Inform Assoc source
May combine two claims.
PremisecitationRecent omics-based diagnostic models illustrate both the promise of transferring single-cell or molecular signatures across bulk and single-cell sequencing data and the dependence of such models on platform compatibility, normalization, and cohort-specific processing choices.
“Recent omics-based diagnostic models illustrate both the promise of transferring single-cell or molecular signatures across bulk and single-cell sequencing data and the dependence of such models on platform compatibility, normalization, and cohort-specific processing choices [45–47].”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [45] X Zheng, 2024, scCaT: An explainable capsulating architecture for sepsis diagnosis transferring from single-cell RNA sequencing, PLoS Comput Biol source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [46] R Wang, 2022, Improving bulk RNA-seq classification by transferring gene signature from single cells in acute myeloid leukemia, Brief Bioinform source
- cites [47] N Jin, 2024, PAGE-based transfer learning from single-cell to bulk sequencing enhances model generalization for sepsis diagnosis, Brief Bioinform source
May combine two claims.
Findingown dataCalibration drift emerged consistently across the four systems and often preceded detectable changes in discrimination.
“Calibration drift emerged consistently and often preceded detectable changes in discrimination.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn Systems A and B, AUROC remained close to validation levels during early deployment, whereas calibration slopes declined and calibration intercepts shifted.
“In Systems A and B, AUROC remained close to validation levels during early deployment, whereas calibration slopes declined and calibration intercepts shifted.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataData latency was negatively associated with calibration slope in Systems A, B, and D, but not System C.
“| Data latency | -0.35 (-0.49 to -0.21) | -0.27 (-0.40 to -0.13) | -0.08 (-0.18 to 0.02) | -0.23 (-0.36 to -0.10) |”
Quote in the paperNot a substantial claim- Rests on an assumption: Operational telemetry indicators (input missingness, data latency, feature availability) validly capture workflow-induced drift and are not merely proxies for other unmeasured factors.
The quote only partly states this claim.
Findingown dataOperational telemetry changed over the same period as performance degradation.
“Operational telemetry changed over the same period.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOutcome prevalence shift was negatively associated with calibration slope in Systems A and B, but not Systems C and D.
“| Outcome prevalence shift | -0.18 (-0.28 to -0.08) | -0.16 (-0.26 to -0.06) | -0.07 (-0.16 to 0.02) | -0.08 (-0.18 to 0.01) |”
Quote in the paperSubstantial claim- Rests on an assumption: Outcome labels derived from routine clinical documentation are accurate and consistent enough to serve as ground truth for performance evaluation.
May combine two claims.
Findingown dataIn mature deployment, calibration degradation was more pronounced across Systems A-C, while System D showed a larger decline in discrimination.
“In mature deployment, calibration degradation was more pronounced across Systems A–C, while System D showed a larger decline in discrimination.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFeature availability change preserved the expected direction in most specifications, whereas population demographics showed a small coefficient range, lower incremental explained variance, and inconsistent direction.
“Feature availability change preserved the expected direction in most specifications, whereas population demographics showed a small coefficient range, lower incremental explained variance, and inconsistent direction.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPopulation demographics showed weak and inconsistent associations across all systems, while outcome prevalence showed modest associations in Systems A and B.
“Population demographics showed weak and inconsistent associations across all systems, while outcome prevalence showed modest associations in Systems A and B.”
Quote in the paperSubstantial claimMay combine two claims.
Findingnone givenValidation-era performance met predefined acceptance criteria for all systems and served as the reference for post-deployment comparison.
“Validation-era performance met predefined acceptance criteria for all systems and served as the reference for post-deployment comparison.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMissingness increases were not uniform across feature types; in Systems A and B, the largest increases occurred in time-sensitive EHR inputs, while in Systems C and D, missingness increases were smaller but concentrated in task-specific inputs.
“Missingness increases were not uniform across feature types. In Systems A and B, the largest increases occurred in time-sensitive EHR inputs, including recent vital-sign observations, laboratory values pending at inference time, and structured documentation fields dependent on clinical workflow completion.”
- Also stated in: § 3.4. Longitudinal performance and telemetry trajectories · plain
“In Systems C and D, missingness increases were smaller but were concentrated in task-specific inputs, including delayed laboratory availability and incomplete imaging-derived feature extraction.”
Quote in the paperSubstantial claim- Also stated in: § 3.4. Longitudinal performance and telemetry trajectories · plain
May combine two claims.
Findingown dataOperational telemetry, including missingness and latency, was observable at inference time, while outcome labels became available only after task-dependent delays ranging from days to months.
“Operational telemetry, including missingness and latency, was observable at inference time, while outcome labels became available only after task-dependent delays ranging from days to months (Table 5; Figs 3–4).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataLongitudinal estimates were repeated using alternative temporal aggregation windows; shorter windows increased variability, especially in lower-volume systems, whereas wider windows reduced short-term fluctuation.
“Longitudinal estimates were repeated using alternative temporal aggregation windows. Shorter windows increased variability, especially in lower-volume systems, whereas wider windows reduced short-term fluctuation.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataSystem C showed slower calibration drift, while System D exhibited greater discrimination sensitivity to modality-specific workflow changes.
“System C showed slower calibration drift, while System D exhibited greater discrimination sensitivity to modality-specific workflow changes.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataValidation-to-early-deployment differences in calibration slope were already evident using the 3-month definition and increased modestly under the 6- and 9-month definitions.
“Validation-to-early-deployment differences in calibration slope were already evident using the 3-month definition and increased modestly under the 6- and 9-month definitions.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataMissingness and latency remained negatively associated with calibration slope in all exclusions, and workflow-associated indicators retained greater explanatory contribution than population-related indicators.
“Missingness and latency remained negatively associated with calibration slope in all exclusions, and workflow-associated indicators retained greater explanatory contribution than population-related indicators (Table 2).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Study design and conductnone givenNo changes were made to model parameters, feature definitions, decision thresholds, or intended use during the observation period.
“No changes were made to model parameters, feature definitions, decision thresholds, or intended use during the observation period.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenOutcome labels were derived from routine clinical documentation and were consistent with those used during validation.
“Outcome labels were derived from routine clinical documentation and were consistent with those used during validation.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisereasoningCalibration slope was selected a priori as the primary dependent variable because calibration reflects the reliability of absolute risk estimates used in threshold-based clinical decision support.
“The primary dependent variable for drift-association analyses was calibration slope, selected a priori because calibration reflects the reliability of absolute risk estimates used in threshold-based clinical decision support.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenMinimal preprocessing was applied, and feature handling remained consistent with original model implementation.
“Minimal preprocessing was applied, and feature handling remained consistent with original model implementation.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductnone givenAll systems were evaluated as implemented within existing clinical workflows.
“All systems were evaluated as implemented within existing clinical workflows.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductown dataThe failure modes were derived from the combined evidence in Tables 1, 4, 5 and Figs 1-4.
“These failure modes were derived from the combined evidence in Tables 1, 4, 5 and Figs 1–4.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningValidation should be treated as a conditional snapshot tied to the historical workflow, documentation, and data-pipeline context, challenging the assumption in reporting and procurement that acceptable validation metrics bound future operational risk.
“Validation should therefore be treated as a conditional snapshot tied to the historical workflow, documentation, and data-pipeline context, challenging the assumption in reporting and procurement that acceptable validation metrics bound future operational risk.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Premisenone givenExisting literature establishes a clear consensus that model degradation is expected, common, and potentially harmful.
“Taken together, existing literature establishes a clear consensus that model degradation is expected, common, and potentially harmful.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningIn threshold-based workflows, miscalibration can change the number of patients crossing escalation thresholds, alter alert burden, or create false reassurance, even when AUROC remains within an apparently acceptable range.
“In threshold-based workflows, such miscalibration can change the number of patients crossing escalation thresholds, alter alert burden, or create false reassurance, even when AUROC remains within an apparently acceptable range.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataAcross systems, the failure modes shared a common structure: degradation was progressive, often appeared first in calibration and operational telemetry, and could remain insufficiently visible under discrimination-focused or outcome-label-dependent monitoring.
“Across systems, the failure modes shared a common structure: degradation was progressive, often appeared first in calibration and operational telemetry, and could remain insufficiently visible under discrimination-focused or outcome-label-dependent monitoring.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable). May combine two claims.
PremisereasoningWhat remains insufficiently understood is how degradation manifests during real-world deployment, which drift mechanisms are most influential under routine operating conditions, and which observable signals provide early warning of safety-relevant failure.
“What remains insufficiently understood is how degradation manifests during real-world deployment, which drift mechanisms are most influential under routine operating conditions, and which observable signals provide early warning of safety-relevant failure.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe finding should be interpreted as evidence that workflow-associated telemetry was more closely aligned with degradation in this dataset, not as evidence that population change was absent or irrelevant.
“The finding should be interpreted as evidence that workflow-associated telemetry was more closely aligned with degradation in this dataset, not as evidence that population change was absent or irrelevant.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThese analyses were interpreted as associations between covariate blocks and performance degradation, not as causal decomposition.
“These analyses were interpreted as associations between covariate blocks and performance degradation, not as causal decomposition.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenAll data sources were linked at the inference level and temporally aligned relative to prediction time.
“All data sources were linked at the inference level and temporally aligned relative to prediction time.”
Quote in the paperSubstantial claimMay combine two claims.
PremisereasoningPrior work generally does not address three interrelated questions central to governance: when degradation begins relative to deployment, which observable signals precede outcome-measured failure, and how governance constraints shape observability.
“Despite the breadth of systems represented in Table 7, prior work generally does not address three interrelated questions that are central to governance:”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
InterpretationreasoningThe same governance logic may extend to omics-based clinical AI models.
“Although the present study focused on EHR-, laboratory-, and imaging-derived systems, the same governance logic may extend to omics-based clinical AI models.”
Quote in the paperNot a substantial claim- Rests on an assumption: Omics inputs are not passively observed biological facts; they are generated through laboratory and bioinformatic workflows involving sample handling, sequencing or assay platforms, reagent lots, read depth or coverage, normalization, batch correction, and pipeline versions.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenThe study does not attempt to evaluate compliance with specific regulatory frameworks or to prescribe regulatory thresholds.
“while the study engages with regulatory and governance concepts, it does not attempt to evaluate compliance with specific regulatory frameworks or to prescribe regulatory thresholds.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe analyses focus on detection and characterization of degradation rather than on organizational responses once degradation is identified.
“The analyses focus on detection and characterization of degradation rather than on organizational responses once degradation is identified.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningIf degradation is driven by workflow evolution, documentation changes, or data pipeline failures, then responsibility for safety cannot reside solely with model developers.
“If degradation is driven by workflow evolution, documentation changes, or data pipeline failures, then responsibility for safety cannot reside solely with model developers.”
Quote in the paperNot a substantial claimMay combine two claims.
Premiseown dataDeployment evidence consistently highlights context sensitivity, calibration limitations, and workflow dependence across clinical AI.
“Table 7 shows that deployment evidence consistently highlights context sensitivity, calibration limitations, and workflow dependence across clinical AI.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premiseown dataOperational telemetry data are already collected by most clinical systems, as shown in Table 7, but are rarely analyzed in relation to model safety.
“These data are already collected by most clinical systems, as shown in Table 7, but are rarely analyzed in relation to model safety.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Premisenone givenAs summarized in Table 7, real-world evidence remains fragmented regarding when degradation begins, which signals detect it, and how governance constraints such as label latency limit observability.
“However, as summarized in Table 7, it remains fragmented regarding when degradation begins, which signals detect it, and how governance constraints such as label latency limit observability.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable). May combine two claims.
InterpretationreasoningThe present study supports a telemetry-first monitoring paradigm, in which label-independent signals are used for early warning and triage, while outcome-based reassessment serves as confirmatory evidence rather than the sole trigger for action.
“The present study supports a telemetry-first monitoring paradigm, in which label-independent signals are used for early warning and triage, while outcome-based reassessment serves as confirmatory evidence rather than the sole trigger for action.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenThe study intentionally abstracts across multiple clinical tasks and data modalities.
“The study intentionally abstracts across multiple clinical tasks and data modalities.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningFor omics-based models, the relevant telemetry signals were outside the empirical scope of the present analysis.
“For omics-based models, relevant telemetry may include assay platform, reagent batch, sample quality, sequencing depth, normalization procedures, batch-correction methods, and bioinformatic pipeline version; these were outside the empirical scope of the present analysis.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable). May combine two claims.
InterpretationreasoningThe study shifts emphasis from cross-site transportability toward within-site temporal fragility and motivates telemetry-informed, calibration-aware monitoring over outcome-centric audits as the basis for lifecycle assurance.
“The study shifts emphasis from cross-site transportability toward within-site temporal fragility and motivates telemetry-informed, calibration-aware monitoring over outcome-centric audits as the basis for lifecycle assurance.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Premisenone givenReal-world evidence on clinical AI has expanded beyond retrospective validation to external audits, prospective deployments, and workflow-level evaluations.
“Real-world evidence on clinical AI has expanded beyond retrospective validation to external audits, prospective deployments, and workflow-level evaluations.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningTelemetry-first monitoring reduces dependence on potentially contaminated outcome labels for early safety surveillance, though it does not solve the causal problem of label feedback.
“Telemetry-first monitoring does not solve this causal problem, but it reduces dependence on potentially contaminated outcome labels for early safety surveillance.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningThe study's findings are relevant for organizational governance and quality assurance, particularly in informing how monitoring systems might be designed to align with lifecycle-oriented regulatory expectations.
“The findings are relevant for organizational governance and quality assurance, particularly in informing how monitoring systems might be designed to align with lifecycle-oriented regulatory expectations.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductreasoningThese adaptive responses and feedback mechanisms were not modeled explicitly.
“These adaptive responses and feedback mechanisms were not modeled explicitly.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based).
Premisenone givenLabel latency and policy-dependent outcomes are acknowledged but seldom incorporated into evaluation design.
“Label latency and policy-dependent outcomes are acknowledged but seldom incorporated into evaluation design.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable).
Interpretationown dataThese findings support treating validation as a baseline operating reference rather than a durable safety guarantee.
“These findings support treating validation as a baseline operating reference rather than a durable safety guarantee.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisereasoningDiagnostic confirmation, sepsis adjudication, and specialist grading are typically delayed days to weeks, and downstream outcomes may lag months, so evaluations often identify failures retrospectively rather than enabling early detection.
“Diagnostic confirmation, sepsis adjudication, and specialist grading are typically delayed days to weeks, and downstream outcomes may lag months, so evaluations often identify failures retrospectively rather than enabling early detection.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationExternal audits demonstrate that validation performance does not guarantee acceptable real-world behavior, while prospective and workflow-oriented studies indicate that clinician interaction and operational integration materially shape outcomes.
“External audits (e.g., ESM, EDI) demonstrate that validation performance does not guarantee acceptable real-world behavior, while prospective and workflow-oriented studies (e.g., TREWS, RapidAI) indicate that clinician interaction and operational integration materially shape outcomes.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningThe clinical relevance of calibration drift was interpreted through its effect on absolute risk estimation and threshold-based decision-making rather than through measured clinician acceptability.
“The clinical relevance of calibration drift was interpreted through its effect on absolute risk estimation and threshold-based decision-making rather than through measured clinician acceptability.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataThe study did not include prospectively elicited clinician tolerance thresholds for performance degradation or direct measures of clinician trust, reliance, or abandonment over time.
“The study did not include prospectively elicited clinician tolerance thresholds for performance degradation or direct measures of clinician trust, reliance, or abandonment over time.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThis label feedback can bias outcome-dependent reassessment and make delayed labels difficult to interpret as independent ground truth.
“This can bias outcome-dependent reassessment and make delayed labels difficult to interpret as independent ground truth.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningQuantitative effect sizes and degradation rates from this study should not be interpreted as universal.
“quantitative effect sizes and degradation rates should not be interpreted as universal.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
The four included AI systems are representative of clinically deployed AI systems in general, such that findings about post-deployment fragility generalize to other systems and settings.
“The included systems spanned heterogeneous clinical domains, data modalities, and workflow contexts, including high-frequency EHR-based predictive models and lower-frequency diagnostic and imaging-based applications.”
The paper relies on this without support.
Operational telemetry indicators (input missingness, data latency, feature availability) validly capture workflow-induced drift and are not merely proxies for other unmeasured factors.
“Workflow-induced drift was assessed using operational indicators such as input missingness, data latency, and feature availability.”
The paper relies on this without support.
The validation-era performance metrics are a valid baseline for comparison, and the validation data are comparable to deployment data except for the factors studied.
“The study compared model performance observed during pre-deployment validation with performance measured after deployment”
The paper relies on this without support.
Outcome labels derived from routine clinical documentation are accurate and consistent enough to serve as ground truth for performance evaluation.
“Outcome labels were derived from routine clinical documentation and were consistent with those used during validation.”
The authors state this as an assumption.
Outcome labels are assumed unavailable for real-time safety monitoring.
“Labels delayed days-months, task-dependent, assumed unavailable for real-time safety monitoring.”
The paper relies on this without support.
The four clinically deployed AI systems studied are representative enough that the identified failure modes generalize to other clinical AI systems.
“The analysis is explicitly designed to mirror the observability conditions documented in Table 7 and to extract generalizable failure structures while grounding them in empirical effect magnitudes observed under routine deployment conditions.”
The authors state this as an assumption.
Current practice often treats acceptable discrimination and calibration at validation as sufficient justification for deployment, with the implicit assumption that performance will remain stable unless the model is explicitly updated.
“Current practice often treats acceptable discrimination and calibration at validation as sufficient justification for deployment, with the implicit assumption that performance will remain stable unless the model is explicitly updated.”
The paper relies on this without support.
Calibration governs the correctness of absolute risk estimates that underpin threshold-based decisions, escalation pathways, and clinical trust.
“calibration governs the correctness of absolute risk estimates that underpin threshold-based decisions, escalation pathways, and clinical trust.”
The paper relies on this without support.
Much existing guidance implicitly prioritizes monitoring for population drift, including changes in demographics, case mix, or disease prevalence.
“Much existing guidance implicitly prioritizes monitoring for population drift – changes in demographics, case mix, or disease prevalence.”
The paper relies on this without support.
The clinical consequences of calibration drift differ between early warning systems, autonomous diagnostic tools, and workflow acceleration platforms.
“the clinical consequences of calibration drift differ between early warning systems, autonomous diagnostic tools, and workflow acceleration platforms.”
The paper relies on this without support.
The availability and reliability of telemetry signals may vary by modality and vendor implementation.
“the availability and reliability of telemetry signals may vary by modality and vendor implementation.”
The paper relies on this without support.
In real deployments, health systems may intervene through recalibration, workflow modification, retraining, or temporary suspension, potentially altering observed trajectories.
“In real deployments, health systems may intervene through recalibration, workflow modification, retraining, or temporary suspension, potentially altering observed trajectories.”
The paper relies on this without support.
Omics inputs are not passively observed biological facts; they are generated through laboratory and bioinformatic workflows involving sample handling, sequencing or assay platforms, reagent lots, read depth or coverage, normalization, batch correction, and pipeline versions.
“Omics inputs are not passively observed biological facts; they are generated through laboratory and bioinformatic workflows involving sample handling, sequencing or assay platforms, reagent lots, read depth or coverage, normalization, batch correction, and pipeline versions.”
The paper relies on this without support.
Few published studies document not only when degradation occurs, but also how organizations respond and with what effectiveness.
“few published studies document not only when degradation occurs, but also how organizations respond and with what effectiveness.”
Cites
Collins, G. S., Moons, K. G. M., Dhiman, P., Riley, R. D., Beam, A. L., Van Calster, B., Ghassemi, M., Liu, X., Reitsma, J. B., van Smeden, M., et al. (2024) · BMJ · doi:10.1136/bmj-2023-078378 · Cited by 4,718 · cited 1× · see citing works
“Frameworks such as TRIPOD-AI and CONSORT-AI have substantially improved transparency in model development and validation, and regulatory bodies emphasize ongoing monitoring for AI/ML-enabled medical devices [24].”
Zech, J. R., Badgeley, M. A., Liu, M., Costa, A. B., Titano, J. J., & Oermann, E. K. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002683 · Cited by 1,719 · cited 1× · see citing works
“In medical imaging, Zech et al. showed that a pneumonia detection model learned site-specific and non-clinical confounders, resulting in large performance differences across hospitals despite strong internal validation [14].”
Abràmoff, M. D., Lavin, P. T., Birch, M., Shah, N., & Folk, J. C. (2018) · npj Digital Medicine · doi:10.1038/s41746-018-0040-6 · Cited by 1,638 · cited 1× · see citing works
“Pivotal prospective trial [39] Reference grading days-weeks, referral outcomes months .”
Wong, A., Otles, E., Donnelly, J. P., Krumm, A., McCullough, J., DeTroyer-Cooley, O., Pestrue, J., Phillips, M., Konye, J., Penoza, C., et al. (2021) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2021.2626 · Cited by 995 · cited 3× · see citing works
“Similarly, external evaluations of widely deployed proprietary systems, such as the Epic Sepsis Model, have reported poor discrimination and calibration in routine clinical use despite broad adoption [15,16].”
The Clinician and Dataset Shift in Artificial Intelligence
Finlayson, S. G., Subbaswamy, A., Singh, K., Bowers, J., Kupke, A., Zittrain, J., Kohane, I. S., & Saria, S. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2104626 · Cited by 855 · cited 2× · see citing works
“This supports a workflow-aware interpretation of post-deployment fragility: degradation may be linked to how data are produced within evolving workflows and information systems, not only to who the patients are [8,18,33,35].”
with the HITEC Investigators, Ancker, J. S., Edwards, A., Nosal, S., Hauser, D., Mauer, E., & Kaushal, R. (2017) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-017-0430-8 · Cited by 709 · cited 1× · see citing works
“Complementary work on alert fatigue and automation bias shows that clinician interaction with decision support systems can recursively influence both inputs and outcomes, creating feedback loops that invalidate original performance assumptions [19,20].”
Beede, E., Baylor, E., Hersch, F., Iurchenko, A., Wilcox, L., Ruamviboonsuk, P., & Vardoulakis, L. M. (2020) · Proceedings of the 2020 CHI Conference on Human Factors in Computing Systems · doi:10.1145/3313831.3376718 · Cited by 614 · cited 1× · see citing works
“Prospective program + deployment analysis [43,44] Specialist grading days-weeks, pro-grammatic outcomes months .”
Rivera, S. C., Liu, X., Chan, A.-W., Denniston, A. K., & Calvert, M. J. (2020) · BMJ · doi:10.1136/bmj.m3210 · Cited by 463 · cited 1× · see citing works
“…primarily focus on evidence generation at the point of evaluation and provide limited guidance on how performance degradation should be detected and managed during routine clinical operation, particularly when outcome labels are delayed, incomplete, or influenced by the model’s own use [25–27].”
Adams, R., Henry, K. E., Sridharan, A., Soleimani, H., Zhan, A., Rawat, N., Johnson, L., Hager, D. N., Cosgrove, S. E., Markowski, A., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01894-0 · Cited by 365 · cited 1× · see citing works
“Prospective multi-site evaluation [37,38] Sepsis labels days-weeks, treatment timing minutes-hours .”
Calibration drift in regression and machine learning models for acute kidney injury
Davis, S. E., Lasko, T. A., Chen, G., Siew, E. D., & Matheny, M. E. (2017) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocx030 · Cited by 312 · cited 1× · see citing works
“This extends prior reports of temporal miscalibration [32–34] by showing calibration failure is structural and progressive rather than sporadic.”
From development to deployment: dataset shift, causality, and shift-stable models in health AI
Subbaswamy, A., & Saria, S. (2019) · Biostatistics · doi:10.1093/biostatistics/kxz041 · Cited by 276 · see citing works
Ipp, E., Liljenquist, D., Bode, B., Shah, V. N., Silverstein, S., Regillo, C. D., Lim, J. I., Sadda, S., Domalpally, A., Gray, G., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.34254 · Cited by 256 · cited 1× · see citing works
“Pivotal evaluation [40] Adjudicated DR grade days-weeks, downstream outcomes months .”
Ruamviboonsuk, P., Tiwari, R., Sayres, R., Nganthavee, V., Hemarat, K., Kongprayoon, A., Raman, R., Levinstein, B., Liu, Y., Schaekermann, M., et al. (2022) · The Lancet Digital Health · doi:10.1016/s2589-7500(22)00017-6 · Cited by 250 · cited 1× · see citing works
“Prospective program + deployment analysis [43,44] Specialist grading days-weeks, pro-grammatic outcomes months .”
Detection of calibration drift in clinical prediction models to inform model updating
Davis, S. E., Greevy, R. A., Lasko, T. A., Walsh, C. G., & Matheny, M. E. (2020) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2020.103611 · Cited by 160 · see citing works
Jenkins, D. A., Martin, G. P., Sperrin, M., Riley, R. D., Debray, T. P. A., Collins, G. S., & Peek, N. (2021) · Diagnostic and Prognostic Research · doi:10.1186/s41512-020-00090-3 · Cited by 131 · cited 1× · see citing works
“Statistical analyses were designed to quantify longitudinal divergence between validation-era and post-deployment model behavior and to examine whether this divergence was associated with temporal, population-related, or workflow-associated indicators [31,32].”
Henry, K. E., Adams, R., Parent, C., Soleimani, H., Sridharan, A., Johnson, L., Hager, D. N., Cosgrove, S. E., Markowski, A., Klein, E. Y., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01895-z · Cited by 127 · cited 1× · see citing works
“Prospective multi-site evaluation [37,38] Sepsis labels days-weeks, treatment timing minutes-hours .”
Rahmani, K., Thapa, R., Tsou, P., Chetty, S. C., Barnes, G., Lam, C., & Tso, C. F. (2022) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2022.104930 · Cited by 115 · see citing works
Singh, K., Valley, T. S., Tang, S., Li, B. Y., Kamran, F., Sjoding, M. W., Wiens, J., Otles, E., Donnelly, J. P., Wei, M. Y., et al. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202006-698oc · Cited by 111 · see citing works
Chen, J. H., Alagappan, M., Goldstein, M. K., Asch, S. M., & Altman, R. B. (2017) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2017.03.006 · Cited by 101 · cited 1× · see citing works
“Clinical practice patterns learned from EHR data can vary substantially across years [6].”
Detecting and Remediating Harmful Data Shifts for the Responsible Deployment of Clinical AI Models
Subasri, V., Krishnan, A., Kore, A., Dhalla, A., Pandya, D., Wang, B., Malkin, D., Razak, F., Verma, A. A., Goldenberg, A., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.13685 · Cited by 87 · see citing works
Yahav-Dovrat, A., Saban, M., Merhav, G., Lankri, I., Abergel, E., Eran, A., Tanne, D., Nogueira, R., & Sivan-Hoffmann, R. (2020) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6923 · Cited by 81 · cited 1× · see citing works
“Real-world evaluation in stroke center [41] Final neuroradiology read hours-days ; reperfusion outcomes days .”
Monitoring performance of clinical artificial intelligence in health care: a scoping review
Andersen, E. S., Birk-Korch, J. B., Hansen, R. S., Fly, L. H., Röttger, R., Arcani, D. M. C., Brasen, C. L., Brandslund, I., & Madsen, J. S. (2024) · JBI Evidence Synthesis · doi:10.11124/jbies-24-00042 · Cited by 73 · cited 2× · see citing works
“This supports a workflow-aware interpretation of post-deployment fragility: degradation may be linked to how data are produced within evolving workflows and information systems, not only to who the patients are [8,18,33,35].”
Minne, L., Eslami, S., de Keizer, N., de Jonge, E., de Rooij, S. E., & Abu-Hanna, A. (2012) · Intensive Care Medicine · doi:10.1007/s00134-011-2390-2 · Cited by 69 · see citing works
Automation Bias in AI-Decision Support: Results from an Empirical Study
Kücking, F., Hübner, U., Przysucha, M., Hannemann, N., Kutza, J.-O., Moelleken, M., Erfurt-Berge, C., Dissemond, J., Babitsch, B., & Busch, D. (2024) · Studies in Health Technology and Informatics · doi:10.3233/shti240871 · Cited by 51 · cited 1× · see citing works
“Complementary work on alert fatigue and automation bias shows that clinician interaction with decision support systems can recursively influence both inputs and outcomes, creating feedback loops that invalidate original performance assumptions [19,20].”
Transforming sepsis management: AI-driven innovations in early detection and tailored therapies
Papareddy, P., Lobo, T. J., Holub, M., Bouma, H., Maca, J., Strodthoff, N., & Herwald, H. (2025) · Critical Care · doi:10.1186/s13054-025-05588-0 · Cited by 49 · cited 1× · see citing works
“Similarly, external evaluations of widely deployed proprietary systems, such as the Epic Sepsis Model, have reported poor discrimination and calibration in routine clinical use despite broad adoption [15,16].”
Sustainable deployment of clinical prediction tools—a 360° approach to model maintenance
Davis, S. E., Embí, P. J., & Matheny, M. E. (2024) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocae036 · Cited by 46 · see citing works
Impact of RapidAI mobile application on treatment times in patients with large vessel occlusion
Al‐Kawaz, M., Primiani, C. T., Urrutia, V., & Hui, F. K. (2021) · Journal of NeuroInterventional Surgery · doi:10.1136/neurintsurg-2021-017365 · Cited by 37 · cited 1× · see citing works
“Real-world association with faster treatment [42] Procedural timestamps minutes– hours, outcomes days-months .”
Li, X., Yang, L., Yuan, Z., Lou, J., Fan, Y., Shi, A., Huang, J., Zhao, M., & Wu, Y. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02955-7 · Cited by 36 · see citing works
Wang, R., Zheng, X., Wang, J., Wan, S., Song, F., Wong, M. H., Leung, K. S., & Cheng, L. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac002 · Cited by 34 · see citing works
Challenges for Data Quality in the Clinical Data Life Cycle: Systematic Review
An, D., Lim, M., & Lee, S. (2025) · Journal of Medical Internet Research · doi:10.2196/60709 · Cited by 26 · cited 1× · see citing works
“This objective builds on prior informatics research highlighting the impact of data quality and workflow design on clinical decision support effectiveness [28–30].”
A process model for quality in use evaluation of clinical decision support systems
Souza-Pereira, L., Ouhbi, S., & Pombo, N. G. C. C. (2021) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2021.103917 · Cited by 24 · see citing works
Reps, J., Ryan, P. B., & Rijnbeek, P. R. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-050146 · Cited by 24 · see citing works
Cabanillas Silva, P., Sun, H., Rezk, M., Roccaro-Waldmeyer, D. M., Fliegenschmidt, J., Hulde, N., von Dossow, V., Meesseman, L., Depraetere, K., Stieg, J., et al. (2024) · Journal of Medical Internet Research · doi:10.2196/51409 · Cited by 20 · cited 1× · see citing works
“Longitudinal analyses have shown that predictive models may lose calibration and discrimination over time within the same institution, even when patient demographics and nominal case severity remain relatively stable [9].”
Artificial intelligence in primary care: frameworks, challenges, and guardrails
Allen, L. N., Lin, J., Segal, B., Ndlovu, K., Bilardi, D., & Pettigrew, L. M. (2025) · The Lancet Primary Care · doi:10.1016/j.lanprc.2025.100079 · Cited by 19 · cited 1× · see citing works
“Once embedded into routine care, AI systems become tightly coupled to evolving clinical workflows, documentation practices, information system configurations, and care pathways [4,5].”
On Missingness Features in Machine Learning Models for Critical Care: Observational Study
Singh, J., Sato, M., & Ohkuma, T. (2021) · JMIR Medical Informatics · doi:10.2196/25022 · Cited by 17 · cited 1× · see citing works
“Care-process shifts – especially changes in test-ordering and documentation practices – can alter both feature availability and the meaning of missingness (“informative missingness”), which can affect deterioration-prediction performance even when underlying patient mix is relatively stable [11,12].”
Zheng, X., Meng, D., Chen, D., Wong, W.-K., To, K.-H., Zhu, L., Wu, J., Liang, Y., Leung, K.-S., Wong, M.-H., et al. (2024) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1012083 · Cited by 14 · cited 1× · see citing works
“Recent omics-based diagnostic models illustrate both the promise of transferring single-cell or molecular signatures across bulk and single-cell sequencing data and the dependence of such models on platform compatibility, normalization, and cohort-specific processing choices [45–47].”
Aliferis, C., & Simon, G. (2024) · Health informatics · doi:10.1007/978-3-031-39355-6_12 · Cited by 13 · see citing works
Tay, Y. X., Wee, C. P. J., Ong, M. E. H., Foley, S. J., Chen, R. C., Chan, L. P., Killeen, R. P., Chua, I. S. Y., & McNulty, J. P. (2025) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2025.105966 · Cited by 11 · cited 1× · see citing works
“This objective builds on prior informatics research highlighting the impact of data quality and workflow design on clinical decision support effectiveness [28–30].”
Jin, N., Nan, C., Li, W., Lin, P., Xin, Y., Wang, J., Chen, Y., Wang, Y., Yu, K., Wang, C., et al. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae661 · Cited by 9 · see citing works
Exploring an AI-First Healthcare System
Gates, A., Ali, A., Conard, S. E., & Dunn, P. J. (2026) · Bioengineering · doi:10.3390/bioengineering13010112 · Cited by 8 · cited 1× · see citing works
“Once embedded into routine care, AI systems become tightly coupled to evolving clinical workflows, documentation practices, information system configurations, and care pathways [4,5].”
Armoundas, A. A., & Singh, J. P. (2026) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztag019 · Cited by 8 · cited 1× · see citing works
“Regulatory and reporting guidance increasingly acknowledges the need for lifecycle-based evaluation of AI systems [21–23].”
Sim, T., Hahn, S., Kim, K.-J., Cho, E.-Y., Jeong, Y., Kim, J.-H., Ha, E.-Y., Kim, I.-C., Park, S.-H., Cho, C.-H., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14072213 · Cited by 7 · see citing works
Do, T.-C., Yang, H.-J., Kim, S.-H., Kho, B., & Park, J. K. (2024) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2024.105745 · Cited by 3 · see citing works
Day, P. L., Wieczorek, M. A., Rokke, D., Lantz, E., Bornhorst, J. A., Jannetto, P. J., & Carter, R. E. (2026) · Clinical Chemistry · doi:10.1093/clinchem/hvag001 · Cited by 1 · cited 1× · see citing works
“This supports a workflow-aware interpretation of post-deployment fragility: degradation may be linked to how data are produced within evolving workflows and information systems, not only to who the patients are [8,18,33,35].”
Challenges for Data Quality in the Clinical Data Life Cycle: Systematic Review (Preprint)
An, D., Lim, M., & Lee, S. (2024) · doi:10.2196/preprints.60709
Flagged first, then by citations
Cited by
Sorted by citations
Current Standards of Monitoring Models in Healthcare Settings
Kay, A., Takher, D., Liu, W., Wittrup, E. M., Omenn, G. S., & Najarian, K. (2026) · Advanced Intelligent Discovery · doi:10.1002/aidi.70160
Hu, F., Zhou, X., Zhou, L., et al. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1961816
“Fourth, cross-centre generalisation was substantially weaker than internal validation (30.9% decline), a degradation pattern consistent with the data-heterogeneity effects reported by Kopanitsa (34); the centre-level correlates of this decline (e.g., ρ = +1.000 for co-infection rate) are based on only seven centres an…”
Influential
- Authors
- Kopanitsa, G.
- Affiliations
- ITMO University (RU)
- Corresponding author
- Kopanitsa, Georgy
- ORCID
- Kopanitsa, Georgy
- Venue
- PLOS Digital Health
- Publisher
- Public Library of Science (PLoS)
- Published
- 2026-07-27
- Volume
- 5
- Issue
- 7
- Pages
- e0001534
- ISSN
- 2767-3170 (ISSN-L)
- PMC
- PMC13405297
- OpenAlex
- W7171376340
- Semantic Scholar
- 02ee7672c81e4c67fe9c114265c064a89f6233f1
- Cited by
- 3
- References
- 33
- Citations by year
- 2026: 3
- FWCI
- 5.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLOS Digital Health (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Physical Sciences › Computer Science › Artificial Intelligence › Machine Learning in Healthcare
- Social Sciences › Safety Research › Ethics and Social Impacts of AI
- Keywords
- clinical AI, calibration drift, data availability, data latency, AI governance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-13.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-13.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review